LOGIN  |  REGISTER
Compass Therapeutics

Modivcare to Present at Upcoming Investor Conferences

May 22, 2024 | Last Trade: US$11.13 0.24 2.20

DENVER / May 22, 2024 / Business Wire / Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, announced that L. Heath Sampson, Modivcare’s President and Chief Executive Officer, and Barbara Gutierrez, Modivcare’s Chief Financial Officer, will be attending the upcoming investor conferences:

  • Leerink Partners 2024 Healthcare Crossroads Conference in Austin, Texas. Ms. Gutierrez will participate in a fireside chat presentation on Thursday, May 30, 2024 at 9:40 a.m. Eastern Time and will host investor meetings throughout the day. A link to the live webcast for the presentation can be found here.
  • Jefferies 2024 Global Healthcare Conference in New York, New York. Mr. Sampson and Ms. Gutierrez will participate in a fireside chat presentation on Wednesday, June 5, 2024 at 1:30 p.m. Eastern Time and will host meetings with investors throughout the day. A link to the live webcast for the presentation can be found here.

Links to the live webcasts for each conference can be found on Modivcare’s Investor Relations website at https://investors.modivcare.com/investors/default.aspx. A replay of each presentation will be available for 90 days following the date of the presentation.

About Modivcare

Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB